Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. The Company has a world-class scientific advisory team including recognized global experts... Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. The Company has a world-class scientific advisory team including recognized global experts in pulmonary hypertension. The Company owns North American rights to develop and commercialize levosimendan and has recently released topline data regarding their Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF). For more information, visit www.tenaxthera.com. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.32 | -5.50774526678 | 5.81 | 6.01 | 5.39 | 24352 | 5.62218505 | CS |
4 | 0.54 | 10.9090909091 | 4.95 | 7.2 | 4.93 | 66803 | 5.76485309 | CS |
12 | 1.96 | 55.5240793201 | 3.53 | 7.2 | 3.25 | 64757 | 4.92365389 | CS |
26 | 2.72 | 98.1949458484 | 2.77 | 7.2 | 2.77 | 284070 | 3.89785377 | CS |
52 | -19.278 | -77.8343023256 | 24.768 | 27.3272 | 2.77 | 264109 | 7.38292404 | CS |
156 | -1770.51 | -99.6908783784 | 1776 | 2335.04 | 2.77 | 1608636 | 111.34900519 | CS |
260 | -1866.51 | -99.7067307692 | 1872 | 5888 | 2.77 | 1384534 | 1025.66225383 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.